Supernus Pharmaceuticals Inc.

(SUPN) Trade

By |

Profile

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.

Contact Information

Website: www.supernus.com
Email: gpatrick@supernus.com
Main Phone: +1 301 838-2500
Address: 1550 East Gude Drive
State: MD
City / Town: Rockville
Country: USA
Postal Code: 20850

Issuer Information

Exchange: NSD
CEO: Jack Khattar
Employees: 422
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 57.05 $ -1.3 (-2.23%)
Last Price 57.05 Change $ -1.3 Change % -2.23 Tick N/A
Bid 57.00 Bid Size 200.00 Ask 61.15 Ask Size 2,000.00
Open 58.15 High 58.85 Low 55.65 Prev Close 58.35
Last Trade Volume 1.1 mi 52 Wk Hi 61.10 52 Wk Low 33.30
Market Cap 3 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 51,796,466.00 EPS (TTM) 1.36 PE Ratio 41.90 Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 25 60
Number of Buys 13 29
Number of Sells 12 31
Net Activity -5000 34500
Last 10 Buys Shares
Michael Bigham 1,000
John M. Siebert 1,000
Michael Bigham 1,000
Michael Bigham 1,000
Michael Bigham 1,000
Jack Khattar 1,000
Gregory Patrick 1,000
John M. Siebert 1,000
M. James Barrett 1,000
Charles W. Newhall 1,000
Last 10 Sell Shares
Padmanabh P. Bhatt 1,000
Padmanabh P. Bhatt 1,000
Padmanabh P. Bhatt 1,000
Padmanabh P. Bhatt 1,000
Padmanabh P. Bhatt 1,000
Padmanabh P. Bhatt 1,000
Victor Vaughn 1,000
Victor Vaughn 1,000
Victor Vaughn 1,000
Victor Vaughn 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 68 68 68 68
Low Target Price Estimate 47 47 47 47
Mean Target Price Estimate 57.11 57.11 56 57.11
Standard Deviation 7.41 7.41 7.66 7.41
Date of Most Recent Estimate 06/01/18 05/25/18 05/22/18 06/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 8 8 8 8
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.22 1.22 1.22 1.22